Last quarter (Q3 2023), NexgenRx's total revenue was C$3.39M, an increase of 2.19% from the same quarter last year. In Q3, NexgenRx's net income was C$-130.73K. See NexgenRx’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	C$ 13.47M	C$ 12.78M	C$ 11.84M	C$ 11.04M	C$ 9.54M	C$ 7.17M
Cost of Revenue	C$ 2.70M	C$ 2.60M	C$ 2.03M	C$ 1.38M	C$ 1.17M	C$ 1.13M
Gross Profit	C$ 10.78M	C$ 10.18M	C$ 9.81M	C$ 9.67M	C$ 8.37M	C$ 6.04M
Operating Expense	C$ 10.80M	C$ 9.90M	C$ 7.61M	C$ 7.51M	C$ 8.27M	C$ 6.60M
Operating Income	C$ -21.03K	C$ 287.66K	C$ 2.20M	C$ 2.16M	C$ 93.52K	C$ -557.52K
Net Non Operating Interest Income Expense	C$ -119.76K	C$ -153.19K	C$ 189.39K	C$ -348.23K	C$ -374.40K	C$ -163.44K
Other Income Expense	C$ -28.33K	-	-	-	-	-
Pretax Income	C$ -151.86K	C$ 134.47K	C$ 2.01M	C$ 1.81M	C$ -280.89K	C$ -720.96K
Tax Provision	C$ 158.35K	C$ 156.87K	C$ -2.01M	C$ -305.76K	C$ -72.95K	C$ -24.10K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -310.21K	C$ -22.40K	C$ 4.02M	C$ 2.12M	C$ -207.94K	C$ -696.86K
Basic EPS	C$ -0.01	-	C$ 0.06	C$ 0.03	C$ >-0.01	C$ -0.01
Diluted EPS	C$ -0.01	-	C$ 0.05	C$ 0.03	C$ >-0.01	C$ -0.01
Basic Average Shares	C$ 281.54M	C$ 70.34M	C$ 70.34M	C$ 69.92M	C$ 69.92M	C$ 68.23M
Diluted Average Shares	C$ 296.94M	C$ 75.20M	C$ 74.84M	C$ 74.19M	C$ 69.92M	C$ 68.23M
Dividend Per Share	C$ 0.01	C$ 0.01	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	C$ 9.82K	C$ 24.57K	C$ 244.31K
Total Expenses	C$ 13.49M	C$ 12.49M	C$ -9.64M	C$ 8.88M	C$ 9.45M	C$ 7.73M
Net Income From Continuing And Discontinued Operation	C$ -310.21K	C$ -22.40K	C$ 4.02M	C$ 2.12M	C$ -207.94K	C$ -696.86K
Normalized Income	C$ -78.56K	C$ 98.83K	C$ 1.87K	C$ 2.12M	C$ -207.94K	C$ -696.86K
Interest Expense	-	-	-	C$ 208.55K	C$ 264.11K	C$ 83.28K
EBIT	C$ -32.10K	C$ 287.66K	C$ 2.07M	C$ 2.02M	C$ -16.78K	C$ -637.69K
EBITDA	C$ 1.14M	C$ 1.69M	C$ 3.40M	C$ 2.96M	C$ 815.97K	C$ -320.56K

Currency in CAD

NexgenRx Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing